Our research focused on determining whether BMD-001S could effectively modulate miR-485-3p-mediated regulation of PGC-1α activity during ALS progression and improve motor neuron function in an ALS mouse model. Here, PPARGC1A is linked to amyotrophic lateral sclerosis.